Nuvelution, which is aiming to bring a collaborative element to drug development, has raised an undisclosed amount in a Novo-backed series A round.

The healthcare research services provider will contribute $50m of the capital as an anchor investor and seek to fund China and US-based portfolio companies.

The GlaxoSmithKline spin-out, which is working on treatments for hearing disorders, has raised additional funds to extend the Pfizer-backed round to $36.6m.

The agribusiness venture fund, backed by partners including Tereos, AG2R-La Mondiale and Groupama, has funded eight companies since its April 2014 formation.

Mitsui and Founders Fund provided the funding, which will support the consumer genomics company's international expansion.

The Walt Disney-backed accelerator, run in co-operation with Techstars, has announced the 10 startups that will make up its second class.

Molecular diagnostics platform Xagenic, backed by peer Qiagen and spun out of University of Toronto, boosted its total funding to more than $52m in the round.

The genome research company, which includes IDG among its investor base, has raised more than $70m in total.

Novartis-backed GenSight, which is developing eye disease treatments, raised almost $42m in its only publicly disclosed funding round.

Mitsui, McKesson and existing investors AMN Healthcare jointly provided $9.1m in funding for remote pharmacy management platform PipelineRx.